Analyst consensus rating
Dare Bioscience Analyst Rating: Strong Buy
Direct answer
Dare Bioscience's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.33.
Forecast evidence checked October 18, 2026.
Get free Dare Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.72
- Average price target
- $8.33
- High price target
- $12.00
- Low price target
- $5.00
- Low target gap
- +590%
- Target upside
- +1,050.1%
- High target gap
- +1,556.1%
- Target range width
- 966.1%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Dare Bioscience?
Dare Bioscience has a verified Strong Buy consensus. The same dataset has an average price target of $8.33.
How far are Dare Bioscience's low and high targets from the recorded price?
The low target implies +590%, while the high target implies +1,556.1%.
How many analysts are included in Dare Bioscience's consensus?
The verified consensus includes 3 analysts.
How is Dare Bioscience's target upside or downside calculated?
The average target of $8.33 is divided by the recorded price of $0.72, then one is subtracted to produce +1,050.1%. This does not guarantee a future return.
When was Dare Bioscience's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.